SCHEMBL1806148

SCHEMBL1806148

CCOC(=O)c1n[nH]c(-c2c(F)cccc2F)c1C=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.45
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
NPSR1 Q6W5P4 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.38
TP53 P04637 1/20 0.37
NLRP3 Q96P20 1/20 0.37
ALDH1A1 P00352 2/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809016 0.87 KDM4E (0.48) KDM4EPOLBKMT2AMEN1NPSR1
SCHEMBL1803979 0.86 TDP2 (0.43) KDM4EPOLBKMT2AMEN1NPSR1
SCHEMBL1806327 0.76 KDM4E (0.44) KDM4EPOLBSMN1; SMN2CYP1A2ALDH1A1
SCHEMBL1805096 0.75 PDE4D (0.47) KDM4EKMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL1807976 0.74 MAPT (0.43) KDM4EPOLBNPSR1SMN1; SMN2TP53
SCHEMBL1806149 0.73 HCAR2 (0.42)
SCHEMBL14471201 0.73 SMN1; SMN2 (0.49) KDM4EPOLBKMT2AMEN1NPSR1
SCHEMBL23529298 0.72 TSHR (0.56) KDM4EPOLBKMT2AMEN1NPSR1
SCHEMBL3810014 0.70 KDM4E (0.58) KDM4EPOLBKMT2AMEN1NPSR1
SCHEMBL1806508 0.70 PDE4D (0.49) KDM4EPOLBKMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed